关注的表达:电热贴片驱动通过皮肤输送胰岛素
Quentin Pagneux1,2, Ran Ye3, Li Chengnan1
1Univ. Lille, CNRS, Centrale Lille, Yncréa ISEN, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, F-59000 Lille, France. sabine.szunerits@univ-lille.fr.
Nanoscale horizons
|February 20, 2025
概括
电热贴片为通过皮肤输送胰岛素提供了一种新的方法. 这项技术旨在通过皮肤实现有效的药物运输来改善糖尿病管理.
科学领域:
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
背景情况:
- 糖尿病需要有效的胰岛素管理.
- 通过皮肤输送药物提供了注射的最少侵入性的替代方案.
- 现有的透皮方法面临的挑战是胰岛素的分子大小和皮肤屏障特性.
研究的目的:
- 研究电热贴片在通过皮肤输送胰岛素方面的潜力.
- 探索电气和热刺激如何增强通过皮肤透胰岛素.
- 评估这种新型药物输送系统的可行性和效率.
主要方法:
- 电热贴片的开发和制造.
- 在体外和体外对胰岛素透的测试.
- 利用电和热梯度来促进皮肤间的传输.
- 贴片性能和胰岛素输送功效的表征.
主要成果:
- 电热贴片显著增强了通过皮肤输送胰岛素.
- 优化的电热参数导致了高效的胰岛素透.
- 这些贴片被证明能够通过皮肤传递治疗性胰岛素剂量.
结论:
- 电热贴片代表了非侵入性胰岛素输送的有希望的技术.
- 这种方法可以为糖尿病管理提供更方便,更为患者友好的替代方案.
- 需要进一步的研究来优化该系统的临床应用.
相关概念视频
Drug Delivery: Miscellaneous Routes
303
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
303
Insulin Formulations: Types and Delivery
160
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
160
Drug Delivery: Parenteral Route
374
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
374
Drug Delivery: Overview
271
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
271
Drug Delivery: Enteral Route
372
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
372
Insulin: Dosing Regimen and Adverse Effects
139
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
139


